ÆüËÜÇÀ·Ý²½³Ø²ñ 2021ǯÅÙÂç²ñ¥×¥í¥°¥é¥à¸¡º÷

¥ª¥ó¥é¥¤¥óŸ¼¨²ñ (¥í¥°¥¤¥ó¤¬É¬ÍפǤ¹)
½ªÎ»¤·¤Þ¤·¤¿
¥×¥í¥°¥é¥à½¸PDF ´ë¶ÈÀâÌÀ²ñ
½ªÎ»¤·¤Þ¤·¤¿
¿Ê¹ÔÃæ¤Î¥×¥í¥°¥é¥à°ìÍ÷
½ªÎ»¤·¤Þ¤·¤¿
Âç²ñ¥È¥Ã¥×¥Ú¡¼¥¸¤ËÌá¤ë
Âç²ñ¥×¥í¥°¥é¥à½¸¡¦Âç²ñ¹Ö±éÍ׻ݽ¸¡ÎPDF¡Ï¤ÎÊѹ¹ (¹¹¿·¡§3/24)
¼ø¾Þ¼°¡¦¼õ¾Þ¹Ö±éÆ°²è¤¬¸ø³«¤µ¤ì¤Þ¤·¤¿¡£
¢¨¸ø³«´ü´Ö¡§2021ǯ5·î14Æü¡Á2022ǯ2·îËöÆü¤Þ¤Ç
¿ä¾©¥Ö¥é¥¦¥¶¡§Chrome¡¢FireFox¡¢Edge¡¢Safari
(Internet Explorer¤Ç¤ÏÀµ¤·¤¯É½¼¨¤µ¤ì¤Ê¤¤¾ì¹ç¤¬¤¢¤ê¤Þ¤¹)
4D04-14
°ìÈֱ̹é
¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à D
¥¢¥ì¥ë¥®¡¼¥â¥Ç¥ë¥Þ¥¦¥¹¤Ë¤ª¤±¤ë4,8-¥¹¥Õ¥£¥ó¥¬¥¸¥¨¥Ë¥óΩÂΰÛÀ­ÂΤι³¥¢¥ì¥ë¥®¡¼³èÀ­
Anti-allergic activity of 4,8-sphingadienine stereoisomers in allergy model mice
¡ûÀ¶¿å ÍÚ²Ï1Ãæ¼ °ï´ø1µ×À¤ ²í¼ù1Âç¸Í ¿®ÌÀ2úɸ¶ ¹ÀÀ¿2¿åÌî ²í»Ë1
¡ûHaruka SHIMIZU1 Ikki NAKAMURA1 Masaki KUSE1 Nobuaki OHTO2 Hiroshige KUWAHARA2 Masashi MIZUNO1
1¿À¸ÍÂ籡ÇÀ¡¢2´ÝÁ±À½Ìô³ô¼°²ñ¼Ò
1Kobe Univ., 2Maruzen Pharmaceuticals Co., Ltd.
4,8-sphingadienine / stereoisomer / mast cell

Í×»ÝËÜʸ¤Ï¥È¥Ã¥×¥Ú¡¼¥¸¤«¤é¥í¥°¥¤¥ó¤ò¤·¤Æĺ¤¯¤Èɽ¼¨¤µ¤ì¤Þ¤¹¡£